mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.0043 |
0.9 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |